Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live

Sun Pharma & United States

12 shared events · Importance 5 · Last updated Jun 08, 2026

Importance
5
Shared Events
12
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the NewsDesk Dashboard
59
Regulatory
Sun Pharma: Sun Pharma>>> is responsible for the commercialization of AVT16 under a partnership with Alvogen>>>, which could expand its product portfolio if approved.
United States: The United States>>> is the market where the United States — Food and Drug Administration>>> accepted the BLA for AVT16, potentially expanding biosimilar options for patients and healthcare providers.
Jun 08, 2026 · 11 articles
55
Business
Sun Pharma: Sun Pharma>>> is partnered with Alvogen>>> for the commercialization of AVT05 and AVT06. The resubmission of BLAs by Alvogen>>> is a positive development for Sun Pharma>>> as it moves closer to potentially commercializing these biosimilars.
United States: The United States>>> is the target market for the biosimilar applications, with the United States — Food and Drug Administration>>> (FDA) being the regulatory authority for approval.
Jun 04, 2026 · 10 articles
37
International
Sun Pharma: Sun Pharma>>> was among the winners in the S&P BSE Sensex>>> firms, suggesting strength in the pharmaceutical sector.
United States: Renewed tensions between the United States and Iran unsettled investor sentiment in Indian and other Asian equity markets.
Jun 04, 2026 · 19 articles
19
Business
Sun Pharma: Sun Pharma is mentioned as a company from which Bleichmar Fonti & Auld LLP previously recovered $420 million.
United States: Three U.S. gambling regulators have commenced reviews into Sportradar, indicating potential regulatory scrutiny and impact on the company's operations within the United States.
Apr 23, 2026 · 383 articles
0
International
Sun Pharma: Sun Pharma was among the firms that saw declines in the S&P BSE Sensex.
Jan 08, 2026 · 7 articles
0
Business
Sun Pharma: Sun Pharma is mentioned as a past success for Bleichmar Fonti & Auld LLP, where the firm recovered $420 million. This is a historical reference and not directly related to the current event.
United States: The class action lawsuit is filed in a district court within the United States, indicating the legal jurisdiction of the event.
May 18, 2026 · 236 articles
0
Business
Sep 28, 2025 · 6 articles
0
Business
Feb 24, 2026 · 6 articles
0
International
Apr 02, 2026 · 6 articles
0
International
Apr 01, 2026 · 6 articles
0
International
Apr 23, 2026 · 34 articles
0
Domestic
Apr 27, 2026 · 7 articles
NEWSDESK
Explore this relationship live

Track how Sun Pharma and United States interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.